Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Exchange Rate Effect (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 3 years of Exchange Rate Effect data on record, last reported at $14000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect changed N/A year-over-year to $14000.0; the TTM value through Dec 2025 reached -$32000.0, changed N/A, while the annual FY2025 figure was -$32000.0, N/A changed from the prior year.
  • Exchange Rate Effect reached $14000.0 in Q4 2025 per MRVI's latest filing, up from -$8000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $73000.0 in Q1 2025 and bottomed at -$133000.0 in Q4 2021.